BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18579208)

  • 1. Cartilage proteoglycan-specific T cells as vectors of immunomodulatory biologicals in chronic proteoglycan-induced arthritis.
    Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Lafeber FP; Broeren CP; van Eden W; Broere F
    Mol Immunol; 2008 Aug; 45(13):3526-35. PubMed ID: 18579208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response.
    Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Broeren CP; van Eden W; Broere F
    J Immunol; 2008 Feb; 180(3):1373-81. PubMed ID: 18209031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
    Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
    Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice.
    Buzás EI; Brennan FR; Mikecz K; Garzó M; Negroiu G; Holló K; Cs-Szabó G; Pintye E; Glant TT
    J Immunol; 1995 Sep; 155(5):2679-87. PubMed ID: 7544381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis.
    Kim SH; Lechman ER; Kim S; Nash J; Oligino TJ; Robbins PD
    Mol Ther; 2002 Nov; 6(5):591-600. PubMed ID: 12409257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteoglycan-reactive T cell lines and hybridomas from mice with proteoglycan-induced arthritis.
    Leroux JY; Poole AR; Webber C; Vipparti V; Choi HU; Rosenberg LC; Banerjee S
    J Immunol; 1992 Apr; 148(7):2090-6. PubMed ID: 1372024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
    Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
    Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
    Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
    J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation.
    Glant TT; Buzás EI; Finnegan A; Negroiu G; Cs-Szabó G; Mikecz K
    J Immunol; 1998 Apr; 160(8):3812-9. PubMed ID: 9558085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.
    Glant TT; Bárdos T; Vermes C; Chandrasekaran R; Valdéz JC; Otto JM; Gerard D; Velins S; Lovász G; Zhang J; Mikecz K; Finnegan A
    Arthritis Rheum; 2001 Mar; 44(3):682-92. PubMed ID: 11263784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen.
    Setoguchi K; Misaki Y; Araki Y; Fujio K; Kawahata K; Kitamura T; Yamamoto K
    J Immunol; 2000 Nov; 165(10):5980-6. PubMed ID: 11067961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators and autopathogenic effector cells in proteoglycan-induced arthritic and clinically asymptomatic BALB/c mice.
    Buzás EI; Mikecz K; Brennan FR; Glant TT
    Cell Immunol; 1994 Oct; 158(2):292-304. PubMed ID: 7923385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis.
    Buzás EI; Végvári A; Murad YM; Finnegan A; Mikecz K; Glant TT
    Cell Immunol; 2005 Jun; 235(2):98-108. PubMed ID: 16185673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT; Mikecz K
    Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice.
    Szántó S; Bárdos T; Gál I; Glant TT; Mikecz K
    Arthritis Rheum; 2004 Sep; 50(9):3012-22. PubMed ID: 15457471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation.
    Berlo SE; van Kooten PJ; Ten Brink CB; Hauet-Broere F; Oosterwegel MA; Glant TT; Van Eden W; Broeren CP
    J Autoimmun; 2005 Nov; 25(3):172-80. PubMed ID: 16257179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis.
    Geurts J; Arntz OJ; Bennink MB; Joosten LA; van den Berg WB; van de Loo FA
    Gene Ther; 2007 Dec; 14(23):1632-8. PubMed ID: 17851546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.